Israel Englander’s CASI Pharmaceuticals CASI Stock Holding History

Israel Englander’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,250	Closed	-$156K	–	7005
2022 Q1	$156K	Sell	19,250 -18,921	-50%	-$149K	﹤0.01%	5948
2021 Q4	$305K	Sell	38,171 -43,240	-53%	-$431K	﹤0.01%	5523
2021 Q3	$969K	Sell	81,411 -29,810	-27%	-$403K	﹤0.01%	4728
2021 Q2	$1.72M	Buy	111,221 +102,742	+1,212%	+$1.73M	﹤0.01%	4136
2021 Q1	$203K	Sell	8,479 -4,423	-34%	-$124K	﹤0.01%	5488
2020 Q4	$381K	Sell	12,902 -51,163	-80%	-$1.11M	﹤0.01%	4412
2020 Q3	$980	Buy	+64,065	New	+$1.21M	﹤0.01%	3143
2018 Q3	–	Sell	-1,787	Closed	-$147K	–	3920
2018 Q2	$147K	Sell	1,787 -41,243	-96%	-$2.78M	﹤0.01%	3609
2018 Q1	$1.79M	Buy	43,030 +38,809	+919%	+$1.45M	﹤0.01%	2382
2017 Q4	$137K	Buy	+4,221	New	+$115K	﹤0.01%	3604
2015 Q4	–	Sell	-1,720	Closed	-$18K	–	3429
2015 Q3	$18K	Buy	+1,720	New	+$24.8K	﹤0.01%	3393

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's CASI Position: Q2 2022 in Review

Israel Englander sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 19,250 shares — an estimated $156K sold.

Israel Englander first reported a position in CASI in Q3 2015 and held it in 11 quarters. The position peaked at $1.79M in Q1 2018. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

Israel Englander reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Israel Englander sold 19,250 CASI Pharmaceuticals shares in Q2 2022, an estimated $156K.
Israel Englander first reported a position in CASI Pharmaceuticals in Q3 2015 and held it in 11 quarters.
Israel Englander's CASI Pharmaceuticals position peaked at $1.79M in Q1 2018.
24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.